📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
NEUTRAL
TOTAL VIEWS
2
RECENT COVERAGE · 3 ARTICLES
INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
INmune Bio announced favorable international patent developments for its CORDStrom platform, securing composition-of-matter and...
INmune Bio Wins MHRA Nod For Ebstrocel Pediatric Investigation Plan, Shares Slip Pre-Market
INmune Bio (INMB) secured regulatory approval from the UK's MHRA for a Pediatric Investigation Plan covering Ebstrocel, a candidate...
INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
INmune Bio has secured MHRA written alignment from the UK regulatory authority, confirming that pre-marketing authorization Scientific...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice